Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
Abstract The genus Schistosoma causes a schistosomiasis which is one of the neglected tropical diseases that pose a major threat to public health in East Africa. Praziquantel (PZQ) is the first line drug to treat human schistosomiasis. However, there is scarcity of pooled and summarized data on PZQ...
Saved in:
Main Authors: | Miseganaw Sisay, Tadesse Hailu, Destaw Damtie, Kindu Geta, Lamesgen Zelalem, Degisew Misganaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84621-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Praziquantel on Preventing Delayed Infection of <i>Schistosoma japonicum</i> in Buffaloes and Goats
by: Xiang Gui, et al.
Published: (2024-12-01) -
Parasitological and clinical correlates of Plasmodium–Schistosoma mansoni co-infection and its determinants among Plasmodium-infected patients in the Wolaita Zone, South Ethiopia regional state
by: Kemal Mohamed, et al.
Published: (2025-01-01) -
Merck Open Global Health Library in vitro screening against Schistosoma mansoni identified two new substances with antischistosomal activities for further development
by: Monique Evelyn Ueberall, et al.
Published: (2025-02-01) -
Pharmacological evidence supporting a role for IL-1, IL-2 and serotonin in the inflammation induced by Schistosoma mansoni Soluble Egg Antigen (SEA) in rat paws
by: C. M. F. Pacheco, et al.
Published: (1998-01-01) -
Intestinal schistosomiasis in remote areas of Southwest Ethiopia, a target region for large-scale mass drug administration
by: Yared Nigusu, et al.
Published: (2025-01-01)